// App-Quantinova.ai

: A Functional Composite Endpoint to Characterize Disease Progression in Patients with Active or Non-active Secondary Progressive Multiple Sclerosis

Researchers

Presenter

  • Ludwig Kappos

Principal Investigators

  • Bruce A.C. Cree

  • Amit Bar-Or

  • Ralf Gold

  • Patrick Vermersch

  • Robert J. Fox

  • Ralph Benedict

  • Sophie Arnould

  • Goeril Karlsson

  • Daniela Piani Meier

  • Frank Dahlke

  • Thomas Hach

  • Gavin Giovannoni

Medical Centers

  • Neurologic Clinic and Policlinic and Research Center for Clinical Neuroimmunology and Neuroscience, Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland

  • Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA San Francisco CA United States

  • Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

  • Department for Neurology, St. Josef-Hospital, Ruhr University, Bochum, Germany

  • Univ. Lille, Inserm UMR U1172 LilNCog, CHU Lille, FHU Imminent, Lille, France

  • Mellen Center for Treatment and Research in Multiple Sclerosis, Neurological Institute, Cleveland, OH, USA

  • Department of Neurology, University at Buffalo, Buffalo, NY

  • Novartis AG, Basel, Switzerland

  • Blizard Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK

Locations

  • Switzerland

  • United States

  • Germany

  • France

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Dermatology

  • Genetic Disorder

Disease

  • Multiple Sclerosis

  • Ectodermal dysplasia-syndactyly syndrome

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved